Andreas Pangerl

930 total citations
32 papers, 649 citations indexed

About

Andreas Pangerl is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Andreas Pangerl has authored 32 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 8 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Andreas Pangerl's work include Hepatitis C virus research (12 papers), Circadian rhythm and melatonin (5 papers) and Hepatitis B Virus Studies (5 papers). Andreas Pangerl is often cited by papers focused on Hepatitis C virus research (12 papers), Circadian rhythm and melatonin (5 papers) and Hepatitis B Virus Studies (5 papers). Andreas Pangerl collaborates with scholars based in United States, Germany and Spain. Andreas Pangerl's co-authors include R. J. Reiter, Rüssel J. Reiter, Lois Larsen, Wagner F. Gattaz, Heiner Wedemeyer, Markus Cornberg, R. Rüfer, Gerald R. Buzzell, David Jones and Bo Fu and has published in prestigious journals such as Circulation, Gastroenterology and Biological Psychiatry.

In The Last Decade

Andreas Pangerl

29 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Pangerl United States 12 330 307 93 91 83 32 649
Christian Keicher Germany 13 146 0.4× 144 0.5× 40 0.4× 83 0.9× 140 1.7× 21 634
J. Bosch Belgium 11 102 0.3× 133 0.4× 25 0.3× 10 0.1× 36 0.4× 22 469
Mehmet Boşnak Türkiye 14 108 0.3× 145 0.5× 12 0.1× 38 0.4× 11 0.1× 39 526
Samir Parekh United States 11 221 0.7× 315 1.0× 9 0.1× 27 0.3× 34 0.4× 22 699
Nicoletta Sinelli Italy 12 237 0.7× 201 0.7× 6 0.1× 24 0.3× 24 0.3× 23 447
V. Del Gobbo Italy 11 22 0.1× 148 0.5× 120 1.3× 47 0.5× 65 0.8× 21 614
M Imler France 13 68 0.2× 59 0.2× 47 0.5× 40 0.4× 12 0.1× 67 587
Matthias Banasch Germany 14 46 0.1× 153 0.5× 62 0.7× 19 0.2× 10 0.1× 22 542
W. H. Horner Andrews United Kingdom 15 112 0.3× 90 0.3× 70 0.8× 7 0.1× 52 0.6× 37 580
Kei Mizuno Japan 10 86 0.3× 136 0.4× 14 0.2× 9 0.1× 31 0.4× 21 405

Countries citing papers authored by Andreas Pangerl

Since Specialization
Citations

This map shows the geographic impact of Andreas Pangerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Pangerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Pangerl more than expected).

Fields of papers citing papers by Andreas Pangerl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Pangerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Pangerl. The network helps show where Andreas Pangerl may publish in the future.

Co-authorship network of co-authors of Andreas Pangerl

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Pangerl. A scholar is included among the top collaborators of Andreas Pangerl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Pangerl. Andreas Pangerl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lampertico, Pietro, J.A. Carrión, Michael P. Curry, et al.. (2020). Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysis. Journal of Hepatology. 72(6). 1112–1121. 70 indexed citations
2.
Cornberg, Markus, Francesco Negro, Pietro Lampertico, et al.. (2019). PS-184-Real-world effectiveness and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection: A meta-analysis. Journal of Hepatology. 70(1). e113–e114. 3 indexed citations
3.
Feld, Jordan J., Christophe Moreno, Roger Trinh, et al.. (2015). Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks. Journal of Hepatology. 64(2). 301–307. 110 indexed citations
4.
Manns, Michael P., Ulus Salih Akarca, Ting‐Tsung Chang, et al.. (2012). Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901. Expert Opinion on Drug Safety. 11(3). 361–368. 38 indexed citations
5.
Min, Albert D., Naoky Tsai, Michael P. Manns, et al.. (2010). M1901 Low Rates of Nucleos(T)Ide-Associated Adverse Events in the Long-Term Experience With Entecavir. Gastroenterology. 138(5). S–832.
6.
Manns, M.P., Ting‐Tsung Chang, William Sievert, et al.. (2010). 1016 LOW RATES OF NUCLEOS(T)IDE-ASSOCIATED ADVERSE EVENTS IN THE LONG-TERM EXPERIENCE WITH ENTECAVIR. Journal of Hepatology. 52. S393–S393. 5 indexed citations
7.
Eck, Werner & Andreas Pangerl. (2005). Neue konsulndaten in neuen diplomen. Zeitschrift für Papyrologie und Epigraphik. 152. 229–262. 1 indexed citations
8.
Pangerl, Andreas, David W. Macdonald, & Werner Eck. (2002). Neue diplome für die auxiliartruppen von unterpannonien und die dakischen provinzen aus hadrianischer zeit. 25–50.
9.
Ivanc, Thomas B., et al.. (1999). Corrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarction. American Heart Journal. 138(4). 785–790. 7 indexed citations
10.
Gattaz, Wagner F., et al.. (1992). Accelerated Breakdown of Platelet Membrane Phospholipids in Schizophrenia. Clinical Neuropharmacology. 15. 241B–241B. 4 indexed citations
11.
Pangerl, Andreas, et al.. (1991). Increased platelet membrane lysophosphatidylcholine in schizophrenia. Biological Psychiatry. 30(8). 837–840. 46 indexed citations
12.
Pangerl, Andreas, et al.. (1990). Circadian variations of adrenergic receptors in the mammalian pineal gland: A review. Journal of Neural Transmission. 81(1). 17–29. 63 indexed citations
13.
Buzzell, Gerald R., Andreas Pangerl, Armando Menéndez-Peláez, et al.. (1990). Melatonin and porphyrin in the harderian glands of the syrian hamster: Orcadian patterns and response to autumnal conditions. International Journal of Biochemistry. 22(12). 1465–1469. 9 indexed citations
15.
Pangerl, Andreas, et al.. (1989). ?-Adrenoceptors in the extraorbital lacrimal gland of the Syrian hamster characterization with [125I]-iodopindolol and evidence of sexual dimorphism. Journal of Neural Transmission. 77(2-3). 153–162. 8 indexed citations
17.
Buzzell, Gerald R., Armando Menéndez-Peláez, Tarja Porkka‐Heiskanen, et al.. (1989). Bromocriptine prevents the castration‐induced rise in porphyrin concentration in the harderian glands of the male syrian hamster, Mesocricetus auratus. Journal of Experimental Zoology. 249(2). 172–176. 31 indexed citations
18.
Pangerl, Andreas, et al.. (1989). Twenty-four hour variation of α1-adrenergic receptors in the pineal gland of the male Syrian hamster. Brain Research. 490(1). 166–169. 7 indexed citations
19.
20.
Haen, Ekkehard, et al.. (1988). Circannual variation in the expression of β2-adrenoceptors on human peripheral mononuclear leukocytes (MNLs). Journal of Molecular Medicine. 66(13). 579–582. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026